Company

NANOPHORIA

Rocket Ship Rating

Rocket Ship Rating: 81 out of 100

Next Generation Cardiovascular Treatments via Inhaled Nano‑in‑Micro Technology

Also known as NanoPhoria S.r.l

Biotech & therapeutics
Deeptech

Status: Operatingas of 2026-09-18
Business model: B2B
Founded: 2022
Legal name: NanoPhoria S.r.l

Open relationship map

Claim, correct or request removal

Record updated 29 September 2026

About

NanoPhoria Bioscience is a preclinical-stage biotechnology company

Funding snapshot

Latest round: Series A2026-01

Funding rounds

Series A: 2026-01
Series A: 2025-10
Grant: 2025-02
Seed: 2022-05

Products

Other: NP-MP1